Detergent maker Nirma forays into APIs with Glenmark deal

Ahmedabad-based Nirma is set to acquire Glenmark Life Sciences (GLS), a subsidiary of Glenmark Pharma, for Rs 5,652 crore. This move marks Nirma's entry into the active pharmaceutical ingredient (API) sector and expands its pharmaceutical portfolio, which includes injectables, parentals, and ophthalmic products. GLS specializes in developing APIs for various therapeutic segments.

from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/atg3Jyq

Comments

Popular posts from this blog

Shaky Street: Sensex surges 1.1k points day after 2.2k-point crash

ONGC-NTPC green JV acquires Ayana in $2.3 billion deal

Mobile companies seek zero duty on US imports